Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown ...Middle East

GREENFIELD, Ind., May 5, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEMVY® (lotilaner ophthalmic solution) 0.25%, for the human health application of lotilaner,...

Hence then, the article about elanco sells royalty and milestone rights for lotilaner in human health to blackstone accelerates debt paydown was published today ( Monday 05/05/2025 - 01:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown )

Also on site :

• Coach of softball teams in San Bernardino, Orange counties accused of molesting player
• The Biggest Fitness Trends at CES 2026 (and What I Think About Them)
• Route 59 in Naperville closed after Tesla crashes, bursts into flames